Sean Sullivan is currently
Professor of Pharmacy and Health Services and Director of the
Pharmaceutical Outcomes Research and Policy Program at the
University of Washington. He received his BS in Pharmacy from
Oregon State University, MS in Pharmacy Administration from the
University of Texas and PhD from the University of California at
Berkeley in Health Economics. He joined the University of
Washington in 1990 after completing an NCHSR (now AHRQ) fellowship
at the Institute for Health Policy Studies at the University of
California, San Francisco.
He has authored or co-authored over 100 peer-reviewed publications
and several
book chapters in the areas of economic evaluation and drug policy
focusing primarily on respiratory diseases, mental illness and
immunology. Dr Sullivan has
been active in SMDM, the Academy of Managed Care Pharmacy (AMCP),
the American Lung Association, the American Thoracic Society as
well as ISPOR. He has served as a committee member for the
development of global guidelines for the diagnosis and treatment of
asthma and COPD (GINA, GOLD). Dr. Sullivan chaired the Scientific
Program at the 2001 ISPOR annual meeting.
Recently, Dr. Sullivan has been involved with AMCP in the
development and implementation of a standard format for the
submission of clinical and economic evaluation data to U.S. managed
care plans and pharmacy benefit managers for drug formulary
consideration. His vision for ISPOR is to link the diverse talent
of the membership with the substantial needs of managed care in
order to facilitate assessment of the value of pharmaceuticals. His
hobbies include wine tasting, basketball and spending time with his
wife Catrena and two children, Kiera and Aidan.
Vision Statement by Sean Sullivan MPH,
PhD
The 2005 vision for ISPOR describes an international,
multi-disciplinary society that advances the policy, science, and
practice of health outcomes research. ISPOR is a member-driven
organization that advocates the advancement of good scientific practice
in therapeutic and policy decisions. ISPOR should also be an
organization that works effectively at promoting the application of
health outcomes research. It should use its network of scientists and
teachers to continuously educate the users of health outcomes
information on the value and usefulness of the discipline and its
output. ISPOR members are currently involved at the professional,
science, and practice levels of health outcomes research, but
increasing the involvement of decision makers within ISPOR is needed.
Initiating ongoing collaborations with healthcare practitioners and
relevant payer organizations will strengthen the ability of ISPOR to
affect real changes in decision-making. My goal is to work together
with the leadership of ISPOR to foster an organization that is broad,
inclusive and that values the opinions of all constituents.
